@FiercePharma: In which hep C drugs Incivek and Victrelis go from hit to dud in two years. Report | Follow @FiercePharma
@EricPFierce: Dr. Reddy's, Fujifilm pull plug on Japanese joint venture. Article | Follow @EricPFierce
@CarlyHFierce: ICYMI Friday: Sun Pharma eyeing takeover of Sweden's Meda. Story | Follow @CarlyHFierce
> An FDA panel this week returns to the question of restrictions that the agency imposed on GlaxoSmithKline's ($GSK) diabetes drug Avandia. Story
> Pfizer ($PFE) loses patent protection on Viagra in the U.K. this month. Story
> A recent study found that 83% of cancer doctors report they have had to deal with shortages of oncology drugs and that it has almost affected treatment of their patients. Report
> The EU's Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Union approve Lonquex for the reduction of neutropenia, Teva Pharmaceutical Industries ($TEVA) reported Monday. More
> A study released at ASCO said that an inexpensive test using vinegar reduced cervical cancer rates significantly. Report
@FierceMedDev: Mayo Clinic: Metabolomics could be key to early Alzheimer's blood Dx test. Article | Follow @FierceMedDev
@DamianFierce: Patient selection, biomarkers are key to cancer R&D, Quintiles says. Story | Follow @DamianFierce
@MichaelGFierce: Medtronic triggers summer PMA process for drug-eluting balloon. More | Follow @MichaelGFierce
> WHO approves low-tech Israeli circumcision device. News
> Medtronic triggers summer PMA process for drug-eluting balloon. Article
> Mayo Clinic: Metabolomics could be key to early Alzheimer's blood Dx test. More
> Cochlear downgrades profit forecast as clients await next-gen hearing aid. Story
Biotech News
@FierceBiotech: PR: 1st clinical data presented with ImmunoGen's IMGN853, potential new ovarian cancer therapy. Release | Follow @FierceBiotech
@JohnCFierce: GlaxoSmithKline grabs PhII rheumatoid arthritis drug in MorphoSys deal. Article | Follow @JohnCFierce
@RyanMFierce: Monday at ASCO marked by bad news from $SNY, $LLY after feel-good weekend for $MRK, $BMY. | Follow @RyanMFierce
@EmilyMFierce: New agent stops replication of hep C virus in preclinical studies. Article | Follow @EmilyMFierce
> Boehringer delivers small survival benefit for lung cancer patients. Story
> Clovis soars on upbeat signs of efficacy for targeted cancer drugs. News
> ASCO confab highlights immunotherapies, 'breakthrough' drugs and small victories. More
CRO News
> Quintiles: Patient selection, biomarkers key to cancer R&D. Report
> Unither buys UCB's NY plant. Item
> DKSH ups South Korean presence. Story
> QPS teams with Hepregen for DMPK. More
> UPM buys Pfizer's TN plant, snags CMO deal. Article
Biotech IT News
> Software-backed MTI system spots breast tumors. Item
> OpGen teams with bioinformatics outfit to combat outbreaks. Story
> BT and Accelrys deepen ties for cloud computing in life sciences. Report
> Eli Lilly backs mobile app for cancer docs. News
> Boehringer, Eli Lilly aim to educate diabetics with iPad game. Article
And Finally... India's government issued a statement today defending the domestic generic drug supply as safe in the face of growing concerns after enforcement actions by U.S. regulators against Ranbaxy Laboratories and Wockhardt. Report